[Clinico-immunologic evaluation of the efficacy of bikarfen in allergic dermatoses].

Abstract	It was found that the new native antihistamine and antiserotonin drug bicarphen possesses in patients with allergic dermatoses (eczema and neurodermatitis) more active antihistaminic, anti-inflammatory, antipruritic and antiallergic properties than commonly used drugs, particularly in cases with prevalence of exudative and allergic reactions of the immediate type. Normalization of rosette-forming T-lymphocytes and A and G immunoglobulins was essential.
Authors	Iu M Kashirskiĭ, M E Kaminka, A M Nogaller, K F Fomin
Journal	Vrachebnoe delo (Vrach Delo) Issue 10 Pg. 88-90 (Oct 1989) ISSN: 0049-6804 [Print] Ukraine
Vernacular Title	Kliniko-immunologicheskaia otsenka éffektivnosti bikarfena pri allergicheskikh dermatozakh.
PMID	2575827 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References	Histamine H1 Antagonists Quinuclidines Serotonin Antagonists bicarphene
Topics	Adolescent Adult Antibody Formation (drug effects, immunology) Dermatitis, Atopic (drug therapy, immunology) Drug Evaluation Drug Therapy, Combination Female Histamine H1 Antagonists (therapeutic use) Humans Immunity, Cellular (drug effects, immunology) Male Middle Aged Quinuclidines (therapeutic use) Serotonin Antagonists (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!